DK0849266T3 - Hidtil ukendt polymorf form af doxazosin-mesylat (form III) - Google Patents
Hidtil ukendt polymorf form af doxazosin-mesylat (form III)Info
- Publication number
- DK0849266T3 DK0849266T3 DK96120603T DK96120603T DK0849266T3 DK 0849266 T3 DK0849266 T3 DK 0849266T3 DK 96120603 T DK96120603 T DK 96120603T DK 96120603 T DK96120603 T DK 96120603T DK 0849266 T3 DK0849266 T3 DK 0849266T3
- Authority
- DK
- Denmark
- Prior art keywords
- doxazosin mesylate
- new polymorphic
- iii
- form iii
- polymorphic form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96120603A EP0849266B8 (de) | 1996-12-20 | 1996-12-20 | Neue polymorphe Form von Doxazosinmesylat (Form III) |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0849266T3 true DK0849266T3 (da) | 2007-06-04 |
Family
ID=8223531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96120603T DK0849266T3 (da) | 1996-12-20 | 1996-12-20 | Hidtil ukendt polymorf form af doxazosin-mesylat (form III) |
Country Status (16)
Country | Link |
---|---|
US (1) | US6140334A (zh) |
EP (1) | EP0849266B8 (zh) |
JP (1) | JP4657393B2 (zh) |
KR (1) | KR100659927B1 (zh) |
AT (1) | ATE353892T1 (zh) |
AU (1) | AU725253B2 (zh) |
CA (1) | CA2225022C (zh) |
DE (1) | DE59611417D1 (zh) |
DK (1) | DK0849266T3 (zh) |
ES (1) | ES2282997T3 (zh) |
HU (1) | HU228306B1 (zh) |
IL (1) | IL122630A (zh) |
NZ (1) | NZ329406A (zh) |
PT (1) | PT849266E (zh) |
TW (1) | TW442484B (zh) |
ZA (1) | ZA9710634B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
DE19800214A1 (de) | 1998-01-06 | 1999-07-15 | Knoll Ag | Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür |
ES2164520B1 (es) * | 1999-03-16 | 2003-04-01 | Medichem Sa | "procedimiento de obtencion del polimorfo a del mesilato de doxazosina" |
DE19912063A1 (de) * | 1999-03-18 | 2000-09-21 | Knoll Ag | Neues Verfahren zur Herstellung von Doxazosin-Mesylat in einer als Form A bezeichneten Kristallmodifikation |
DE19912573A1 (de) * | 1999-03-19 | 2000-09-21 | Knoll Ag | Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D |
WO2009081087A1 (en) | 2007-12-24 | 2009-07-02 | Cipla Limited | Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof |
CN109988158A (zh) * | 2018-01-03 | 2019-07-09 | 合肥立方制药股份有限公司 | X晶型、含有x晶型的多沙唑嗪甲磺酸盐及其制备方法和用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2699054A (en) * | 1953-10-09 | 1955-01-11 | Lloyd H Conover | Tetracycline |
US4092315A (en) * | 1976-03-01 | 1978-05-30 | Pfizer Inc. | Novel crystalline forms of prazosin hydrochloride |
GB1591490A (en) * | 1977-08-04 | 1981-06-24 | Abbott Lab | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate |
US4188390A (en) | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
DK154082C (da) * | 1977-11-05 | 1989-02-27 | Pfizer | Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf |
ATE72244T1 (de) * | 1986-03-21 | 1992-02-15 | Heumann Pharma Gmbh & Co | Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung. |
EP0459666B1 (en) * | 1990-05-31 | 1994-11-09 | Pfizer Inc. | Medicaments against impotence |
WO1994009783A1 (en) * | 1992-11-04 | 1994-05-11 | Sepracor, Inc. | Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
US5294615A (en) * | 1993-04-29 | 1994-03-15 | Abbott Laboratories | Terazosin polymorph and pharmaceutical composition |
US5412095A (en) * | 1993-04-29 | 1995-05-02 | Abbott Laboratories | Terazosin monohydrochloride and processes and intermediate for its production |
US5504207A (en) * | 1994-10-18 | 1996-04-02 | Abbott Laboratories | Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
-
1996
- 1996-12-20 PT PT96120603T patent/PT849266E/pt unknown
- 1996-12-20 DK DK96120603T patent/DK0849266T3/da active
- 1996-12-20 DE DE59611417T patent/DE59611417D1/de not_active Expired - Lifetime
- 1996-12-20 AT AT96120603T patent/ATE353892T1/de active
- 1996-12-20 EP EP96120603A patent/EP0849266B8/de not_active Expired - Lifetime
- 1996-12-20 ES ES96120603T patent/ES2282997T3/es not_active Expired - Lifetime
-
1997
- 1997-01-01 ZA ZA9710634A patent/ZA9710634B/xx unknown
- 1997-12-03 TW TW086118164A patent/TW442484B/zh active
- 1997-12-16 IL IL12263097A patent/IL122630A/xx not_active IP Right Cessation
- 1997-12-16 NZ NZ329406A patent/NZ329406A/xx not_active IP Right Cessation
- 1997-12-16 CA CA002225022A patent/CA2225022C/en not_active Expired - Lifetime
- 1997-12-16 HU HU9702477A patent/HU228306B1/hu unknown
- 1997-12-17 KR KR1019970070179A patent/KR100659927B1/ko not_active IP Right Cessation
- 1997-12-17 US US08/992,251 patent/US6140334A/en not_active Expired - Lifetime
- 1997-12-17 JP JP36407197A patent/JP4657393B2/ja not_active Expired - Lifetime
- 1997-12-18 AU AU48449/97A patent/AU725253B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA2225022A1 (en) | 1998-06-20 |
HUP9702477A3 (en) | 1999-06-28 |
HU9702477D0 (en) | 1998-03-02 |
KR100659927B1 (ko) | 2007-04-11 |
IL122630A (en) | 2000-02-17 |
HU228306B1 (en) | 2013-03-28 |
JPH10182641A (ja) | 1998-07-07 |
ATE353892T1 (de) | 2007-03-15 |
DE59611417D1 (de) | 2007-03-29 |
EP0849266A1 (de) | 1998-06-24 |
CA2225022C (en) | 2008-10-07 |
NZ329406A (en) | 1998-10-28 |
ES2282997T3 (es) | 2007-10-16 |
AU725253B2 (en) | 2000-10-12 |
JP4657393B2 (ja) | 2011-03-23 |
IL122630A0 (en) | 1998-08-16 |
ZA9710634B (en) | 1998-11-11 |
AU4844997A (en) | 1998-06-25 |
HUP9702477A2 (hu) | 1999-04-28 |
EP0849266B1 (de) | 2007-02-14 |
KR19980064288A (ko) | 1998-10-07 |
PT849266E (pt) | 2007-03-30 |
EP0849266B8 (de) | 2007-10-03 |
TW442484B (en) | 2001-06-23 |
US6140334A (en) | 2000-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS50081B (sr) | N-(3-etinilfenilamino)-6,7-bis (2-metoksietoksi)-4- hinazolinamin mezilat, bezvodni i monohidrat | |
DE59903869D1 (de) | Verwendung von nanoskaligen sterolen und sterolestern | |
DK0906278T3 (da) | Enantiolselektiv syntese af azetidinoner baseret på 3-hydroxy-gamma-lacton | |
DE69733976D1 (de) | Chirurgische Bohrer und Retraktor | |
DK0694039T3 (da) | Derivater af 1,5-benzodiazepin med CCK-antagonistisk og agonistisk virkning | |
NO985293D0 (no) | Nye 2,3-disubstituerte-4(3H)-kinazolinoner | |
FR2717642B1 (fr) | Commande à portes MOS de circuits ballast. | |
SE9901462D0 (sv) | Novel compound | |
NO20012599L (no) | Fremgangsmåte for boring | |
ITTO940756A0 (it) | Procedimento di sintesi vocale mediante concatenazione e parziale so- vrapposizione di forme d'onda. | |
NO307845B1 (no) | FremgangsmÕte for analyse av borestrengvibrasjoner | |
DK0849266T3 (da) | Hidtil ukendt polymorf form af doxazosin-mesylat (form III) | |
NO308226B1 (no) | FremgangsmÕte og borerigg for boring etter olje eller gass | |
TR199501132A2 (tr) | Nörokinin karsitlari (antagonistleri). | |
TR200100885T2 (tr) | 2-Metil-tieno-benzodiazepin formülasyonu | |
ATE264328T1 (de) | Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen | |
DE69903934D1 (de) | Z-pinchquelle von weichen röntgenstrahlung unter verwendung von verdünnungsgas | |
ZA200503925B (en) | Methods of using and compositions comprising (+)-3(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide | |
FI934748A0 (fi) | Foerfarande foer framstaellning av l-5-(2-acetoxipropionylamino)-2,4,6-trijod-isoftalsyradiklorid | |
IL122420A0 (en) | New polymorphic form of doxazosin mesylate (form i) | |
DE69926827D1 (de) | Thermischer Stabilisator und damit thermostabilisierte Halogenharzzusammensetzung | |
ATE219672T1 (de) | Verwendung von (+)-alpha-(2,3-dimethoxyphenyl)- 1(2-(4-fluorophenyl)ethyl-4-piperidinmethanol zur behandlung von depressionen und bipolaren erkrankungen | |
NO985621D0 (no) | FremgangsmÕte og system for boring under anvendelse av skum - skumsammensetning | |
ZA9710633B (en) | New polymorphic form of doxazosin mesylate (form ii) | |
PT963985E (pt) | Derivados de di- ou triaza-espiro(4,5)decano |